Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0964020120120010047
Journal of the Korean Liver Cancer Study Group
2012 Volume.12 No. 1 p.47 ~ p.50
A Case of Improvement of Hypoglycemia by Sorafenib in Hepatocellular Carcinoma
Koh Kwang-Il

Jung Young-Kul
An Jung-Suk
Kwon Oh-Sang
Kim Yun-Soo
Choi Duck-Joo
Kim Ju-Hyun
Abstract
The prevalence of hypoglycemia in hepatocellular carcinoma (HCC) ranged from 4 to 27%. The causes of hypoglycemia in
HCC are two type. Type A is a poorly differentiated tumor with mild to moderate severity of hypoglycemia that occurs in the late stage of the disease. The less common type B tumor is a well-differentiated slow growing tumor in which severe hypoglycemia occurs in early stages of the disease. We reported a case of improvement of hypoglycemia due to HCC by sorafenib.
KEYWORD
Hepatocellular carcinoma, Hypoglycemia, Sorafenib
FullTexts / Linksout information
Listed journal information